FDA Approved: EXEMESTANE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application to bring a generic Exemestane product to market. The sponsor is Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)